Simplifying molecular subtypes of metastatic gastric cancer
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
Simplifying molecular subtypes of metastatic gastric cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )
8 Oct 2019
Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroe...
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal junction cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )
8 Oct 2019
VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer
Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany
VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer ( Dr Dominik Modest - Charité Universitätsmedizin Berlin, Berlin, Germany )
7 Oct 2019
SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer...
Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during the dose escalation phase ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )
4 Oct 2019
IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer
Dr Ramon Salazar - Catalan Institute of Oncology, Barcelona, Spain
IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer ( Dr Ramon Salazar - Catalan Institute of Oncology, Barcelona, Spain )
4 Oct 2019
AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours
Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )
4 Oct 2019
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advan...
Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA
INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours ( Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA )
3 Oct 2019
BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mu...
Prof Josep Tabernero - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Sp...
BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer ( Prof Josep Tabernero - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
30 Sep 2019
ATTRACTION-3: Nivolumab versus chemotherapy in advanced oesophageal squamous cel...
Prof Byoung Chul Cho - Yonsei University, Seoul, South Korea
ATTRACTION-3: Nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma ( Prof Byoung Chul Cho - Yonsei University, Seoul, South Korea )
29 Sep 2019
Advances in the treatment of peritoneal metastases in gastric cancer
Dr Geraldo Alves - Hospital Santa Rosa, Brasil
Advances in the treatment of peritoneal metastases in gastric cancer ( Dr Geraldo Alves - Hospital Santa Rosa, Brasil )
7 Aug 2019
Optimising regorafenib dosing in mCRC
Dr Axel Grothey and Dr Tanios Bekaii-Saab
Optimising regorafenib dosing in mCRC ( Dr Axel Grothey and Dr Tanios Bekaii-Saab )
2 Aug 2019
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
Dr Parag Parikh - Mayo Clinic, Rochester, USA
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer ( Dr Parag Parikh - Mayo Clinic, Rochester, USA )
17 Jul 2019